CompletedNot applicable

Dance/Movement Therapy for Bone Mineral Density in Schizophrenia

NCT05716802 · Hebei Province Veterans Hospital

Closed to entry

Status

Not accepting participants

Not applicable

Phase

Target enrolment

Study sites

Outside the US

What it is testing

Summary

Fractures are common accidents for long-term hospitalized patients with schizophrenia (SZ) in psychiatric hospitals, and once they occur, patients usually endure the pain of fractures for a long time. Accumulating evidence has supported implementing dance/movement therapy (DMT) as a promising intervention for patients with SZ. However, no study has been conducted to investigate its role in balance ability and metabolic parameters in SZ. This study was designed to investigate the treatment outcome of a 12-week DMT intervention on bone mineral density, balance ability, and metabolic profile in patients with SZ using a randomized, controlled trial design.

Summary as written by the trial’s own sponsor and published on ClinicalTrials.gov API v2. It is the sponsor’s description, reproduced unedited, not an assessment by this site.

What counts as success

Primary outcome measures

Bone mineral density measurement
Measured over week 12

A trial succeeds or fails on its primary outcome, declared in advance. Everything else it reports is secondary by definition.

Who can take part

Eligibility, as published

40 Years to 60 Years

Ages

MALE

Sex

Not accepted

Healthy volunteers

Inclusion Criteria: * Clinical diagnosis of schizophrenia using the DSM-V; * male veterans, aged 40 to 60 years with a disease duration of 5 years or more and a long-term hospitalization of 3 years or more; * ability to understand Mandarin Chinese; * legally eligible to sign an informed consent form; * current antipsychotic medication stability for more than 2 years; * reduced bone mass, osteoporosis, and severe osteopenia after bone density analysis; * no comorbid serious physical illness and physical impairments and can cooperate with nurses to complete the general intensity of activity training; * consent for pre- and post-session interviews. Exclusion Criteria: 1\) substance dependence or abuse; 2) hypercalcemia and hyperuricemia; 3) history of kidney stones or renal calculi; 4) lower limb injury and motor dysfunction, and inability to complete DMT intervention for various reasons. \-

Where

1 study site

Facility	City	Region	Country
DMT	Baoding	Hebei	China

On the registry

Contact the trial directly

This site does not enrol anyone and is not involved in this trial. To ask about taking part, use the sponsor’s own contact details on the official registry record, which is also where the most current version of everything above lives.

Before you do, the preparation checklist lists what a site will ask you on a first call and what is worth asking them. It is free and collects nothing.

NCT05716802 on ClinicalTrials.gov →

Last updated in the registry 2024-03-08. Registry records change; this page reflects the data build of 2026-08-25.

Where this trial sits

Substance

Indication

Schizophrenia13